期刊文献+

血管生成拟态和基质金属蛋白酶-2在前列腺癌中的表达及意义 被引量:2

Expression and significance of vasculogenic mimicry and matrix metalloproteinase-2 in prostate cancer
原文传递
导出
摘要 目的研究血管生成拟态(vasculogenic mimicry,VM)在人前列腺癌组织中的分布及与预后的关系,探讨基质金属蛋白酶-2(matrix metalloproteinase-2,MMP-2)在前列腺癌VM形成中的作用。方法选取天津医科大学第二医院1995年1月至2008年12月收治的前列腺癌患者96例。年龄59~72岁,平均(66.7±11.0)岁。术前血清PSA为15.6—76.7μg/L,平均(34.6±1.7)μg/L。术前经MRI检查及穿刺活检均诊断为局灶性前列腺癌。收集前列腺根治性切除术后的组织标本,采用血小板-内皮细胞黏附分子-1(platelet—endothelial cell adhesion molecule-1,PECAM-1/CD31)免疫组化和过碘酸雪夫氏(periodicacid.sciff,PAS)组织化学双重染色后,光镜下观察VM结构,比较VM表达阳性组和阴性组的预后情况,分析VM表达与预后的关系。免疫组化法检测MMP-2在前列腺癌组织中的表达,分析MMP-2蛋白表达与VM形成的关系和作用。结果96例中24例存在VM结构,VM阳性组平均Gleason评分8.0±0.3,PSA(37.7±2.3)μg/L,均高于VM阴性组Gleason评分6.2±0.3,PSA(19.5±2.1)μg/L,差异有统计学意义(P〈0.05)。VM阴性组无生化复发中位生存期96个月,高于VM阳性组无生化复发中位生存期39个月,差异有统计学意义(P〈0.05)。MMP-2表达和VM的形成呈明显正相关(r2=0.60,P〈0.01)。结论前列腺癌组织中VM形成与组织恶性程度相关,肿瘤细胞分泌MMP,2可能促进了VM的形成,VM阳性和MMP-2高表达与前列腺癌预后不良有关。 Objective To find out if an unique blood mode-vasculogenic mimicry (VM) exist in prostate cancer and analyze its relationship with prognosis. Methods The age of the patients was 59 to 72 years, with a mean age of (66.7 + 11.0) years. All had been confirmed as prostate cancer by biopsy. The level of serum PSA was 15.6 to 76.7 μg/L, with a mean level of (34.6 + 1.7) μg/L. A histochemical and immunohistochemical dual staining method for PAS-CD31 and MMP-2 in 96 prostatic adenocarcinomas were conducted to explore if VM exist in prostate cancer, describe its morphology and distribution. The different expression of MMP-2 in VM positive and VM negative tissue were. The clinical data were collected and ana- lyzed to explore the relationship between disease progression and VM. Results Among 96 cases, 24 cases were found VM positive, the others were negative. The boundary membrane of VM was PAS positive, which was continuous or incontinuous. A positive correlation between VM density and high Gleason score were found. The tPSA were higher in the VM positive cases than that in VM negatives. The VM positive patients had poorer prognosis than that of the negatives. The MMP-2 expression was found correlated with VM posi- tive (re = 0.60, P 〈 0.01 ). Conclusions VM exists in the prostate cancer as an independent structure, and it is more common in the high-grade cancer. The progression-free survival of VM positive patients could be worse than the negative. MMP-2 and VM could be the indicators of poor prognosis.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2012年第10期791-794,共4页 Chinese Journal of Urology
基金 天津市科技支撑计划项目(11ZCGYSY02300) 天津医科大学科学基金项目(2010ky48) 高等学校博士学科点科研专项基金(201112021200007)
关键词 前列腺癌 血管生成拟态 基质金属蛋白酶-2 预后 Prostate cancer Vasculogenic mimicry MMP-2 Prognosis
  • 相关文献

参考文献14

  • 1刘明,王建业,万钢,王鑫,王建龙,陈鑫,马宏,朱生才,魏东,万奔,张力青.1995—2008年北京医院前列腺癌诊断状况变迁[J].中华泌尿外科杂志,2011,32(8):535-538. 被引量:28
  • 2王璐,张丽红,李玉林,李一雷,刘湛.基质金属蛋白酶-9及其mRNA在胃癌中的表达与血管新生的关系[J].中华医学杂志,2003,83(9):782-786. 被引量:57
  • 3Maniotis A J, Folberg R, Hess A, et al. Vascular channel forma- tion by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol, 1999, 155 : 739-752.
  • 4Folberg R, Leach L, Valyi-Nagy K, et al. Modeling the behavior of uveal melanoma in the liver. Invest Ophthalmol Vis Sci, 2007, 48 : 2967-2974.
  • 5张诗武,郭华,张丹芳,赵秀兰,谷彦军,孙保存.恶性黑色素瘤血管生成拟态的形态学观察[J].中国肿瘤临床,2005,32(23):1329-1332. 被引量:9
  • 6Basu GD, Pathangey LB, Tinder TL, et al. Mechanisms under- lying the growth inhibitory effects of the cyclo-oxygenase-2 inhibi- tor celecoxib in human breast cancer ceils. Breast Cancer Res, 2005, 7: 422-435.
  • 7Hoffimeyer MR, Wall KM, Dharmawardhane SF. In vitro analy- sis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Cancer Cell Int, 2005, 5 : 11.
  • 8Guzman G, Cotler SJ, Lin AY, et al. A pilot study of vasculo- genic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med, 2007,131 : 1776-1781.
  • 9Sun B, Qie S, Zhang S, et al. Role and mechanism of vasculo- genic mimicry in gastrointestinal stromal tumor. Hum Pathol, 2008, 39 : 444-451.
  • 10Zhang Z, Hart Y, Zhang K, et al. Investigation of vasculogenic mimicry in intracranial hemangiopericytoma. Mol Med Report, 2011, 4: 1295-1298.

二级参考文献23

  • 1Jemal A, Tiwari RC, Murray T, et al. American cancer society: cancer statistics 2004. CA Cancer J Clin, 2004, 54 : 8-29.
  • 2Stephenson RA, Smart CR, Mineau GP, et al. The fall in inci- dence of prostate cancer: on the down side of a PSA induced peak in incidence. Cancer, 1996, 77: 1342-1348.
  • 3Tarone RE, Chu KC, Brawley OW, et al. Implications of stage- specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiology, 2000, 11 : 167-170.
  • 4Ferlay J, Bray F, Pisani P, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55 : 74-108.
  • 5Hankey BF, Feuer E J, Clegg LX, et al. Cancer surveillance se- ries : Interpreting trends in prostate cancer-part I : Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst, 1999, 91: 1017- 1024.
  • 6Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer statistics review, 1975-2001, Bethesda, Md: National Cancer Institute, 2004: 120-124.
  • 7Carroll P, Coley C, McLeod D, et al. Prostate specific antigen best practice policy-part II: prostate cancer staging and post- treatment follow-up. Urology, 2002, 57: 225-227.
  • 8Neutel CI, Gao RN, Blood PA, et al. The changing age distribu- tion of prostate cancer in Canada. Can J Public Health, 2007, 98 : 60-64.
  • 9Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and vitro :vasculogenic mimicry[J]. AMJ Pathol, 1999, 155(3): 739-752
  • 10Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis[J]. AmJ Pathol, 2000, 156(2): 361-381

共引文献91

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部